Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07836400
Half-dose vs Conventional-dose Cetrorelix in ICSI Cycles
Sponsor: Assiut University
View on ClinicalTrials.gov
Summary
This prospective cohort study aims to compare the effectiveness of half-dose (0.125 mg/day) versus conventional-dose (0.25 mg/day) cetrorelix in GnRH antagonist ICSI cycles regarding clinical pregnancy rate in women with BMI ≥25 kg/m².
Official title: Half-dose Versus Conventional-dose Cetrorelix in Antagonist ICSI Cycles: Prospective Comparative Cohort Study
Key Details
Gender
FEMALE
Age Range
18 Years - 34 Years
Study Type
OBSERVATIONAL
Enrollment
160
Start Date
2026-09-20
Completion Date
2028-03-20
Last Updated
2026-09-23
Healthy Volunteers
No